10.09
price down icon1.56%   -0.1597
 
loading
Schlusskurs vom Vortag:
$10.25
Offen:
$10.25
24-Stunden-Volumen:
1.28M
Relative Volume:
0.58
Marktkapitalisierung:
$761.11M
Einnahmen:
$3.64M
Nettoeinkommen (Verlust:
$-87.37M
KGV:
-2.4551
EPS:
-4.11
Netto-Cashflow:
$-86.46M
1W Leistung:
+3.17%
1M Leistung:
+25.03%
6M Leistung:
+65.14%
1J Leistung:
+83.79%
1-Tages-Spanne:
Value
$9.95
$10.31
1-Wochen-Bereich:
Value
$9.66
$10.70
52-Wochen-Spanne:
Value
$3.455
$11.24

Verastem Inc Stock (VSTM) Company Profile

Name
Firmenname
Verastem Inc
Name
Telefon
(781) 292-4200
Name
Adresse
117 KENDRICK STREET, NEEDHAM, MA
Name
Mitarbeiter
78
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
VSTM's Discussions on Twitter

Vergleichen Sie VSTM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VSTM
Verastem Inc
10.11 772.03M 3.64M -87.37M -86.46M -4.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
437.92 112.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
699.15 73.91B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
418.13 56.81B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
893.47 55.46B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
193.88 41.92B 447.02M -1.18B -906.14M -6.1812

Verastem Inc Stock (VSTM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-16 Fortgesetzt Cantor Fitzgerald Overweight
2025-04-10 Eingeleitet Jefferies Buy
2025-03-24 Bestätigt H.C. Wainwright Buy
2024-12-31 Bestätigt BTIG Research Buy
2024-09-30 Eingeleitet Guggenheim Buy
2023-11-21 Fortgesetzt BTIG Research Buy
2023-09-27 Eingeleitet B. Riley Securities Buy
2023-06-15 Hochstufung Mizuho Neutral → Buy
2022-09-07 Fortgesetzt Alliance Global Partners Buy
2022-04-29 Fortgesetzt Cantor Fitzgerald Overweight
2022-04-14 Eingeleitet RBC Capital Mkts Outperform
2022-03-09 Eingeleitet Truist Buy
2021-07-01 Eingeleitet Alliance Global Partners Buy
2021-05-24 Hochstufung BTIG Research Neutral → Buy
2019-06-20 Herabstufung BTIG Research Buy → Neutral
2019-05-10 Herabstufung Raymond James Outperform → Mkt Perform
2018-07-13 Eingeleitet BTIG Research Buy
2018-05-02 Eingeleitet Seaport Global Securities Buy
2018-03-08 Eingeleitet B. Riley FBR, Inc. Buy
2017-09-07 Bestätigt H.C. Wainwright Buy
2017-04-13 Eingeleitet Oppenheimer Outperform
2017-03-24 Bestätigt H.C. Wainwright Buy
2015-09-29 Herabstufung Cantor Fitzgerald Buy → Hold
2015-09-29 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2015-09-29 Herabstufung Jefferies Buy → Hold
2015-09-29 Herabstufung Raymond James Strong Buy → Outperform
2015-09-28 Herabstufung Mizuho Buy → Neutral
2015-09-28 Herabstufung ROTH Capital Buy → Neutral
2015-09-09 Eingeleitet Raymond James Strong Buy
2015-05-12 Bestätigt UBS Buy
2015-04-08 Eingeleitet H.C. Wainwright Buy
2015-01-23 Bestätigt ROTH Capital Buy
2014-07-08 Fortgesetzt Oppenheimer Perform
2014-02-11 Eingeleitet Mizuho Buy
Alle ansehen

Verastem Inc Aktie (VSTM) Neueste Nachrichten

pulisher
Dec 07, 2025

Is Verastem Inc a good long term investmentMACD Trading Signals & Free Expert Guidance For Growth - earlytimes.in

Dec 07, 2025
pulisher
Dec 07, 2025

Will Verastem Inc stock benefit from green energy trends2025 Trading Volume Trends & Verified Stock Trade Ideas - BỘ NỘI VỤ

Dec 07, 2025
pulisher
Dec 07, 2025

132,444 Shares in Verastem, Inc. $VSTM Purchased by Panagora Asset Management Inc. - MarketBeat

Dec 07, 2025
pulisher
Dec 07, 2025

With Verastem Stock Surging, Have You Considered The Downside? - Trefis

Dec 07, 2025
pulisher
Dec 06, 2025

Is Verastem Stock Built to Withstand a Pullback? - Trefis

Dec 06, 2025
pulisher
Dec 06, 2025

Aug Reactions: Why Verastem Inc stock appeals to dividend seekers2025 Sector Review & Technical Pattern Based Signals - BỘ NỘI VỤ

Dec 06, 2025
pulisher
Dec 05, 2025

Verastem (NASDAQ:VSTM) CEO Dan Paterson Sells 2,000 Shares - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Does Verastem Inc. (2VSA) stock trade below intrinsic valueTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Will Verastem Inc. (2VSA) stock outperform energy sector in 2025Market Activity Recap & Accurate Technical Buy Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Will Verastem Inc. (2VSA) stock sustain uptrend momentumPortfolio Growth Summary & Real-Time Buy Signal Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

How supply shortages influence Verastem Inc. (2VSA) stock2025 Price Targets & AI Optimized Trading Strategy Guides - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Why Verastem Inc. stock appeals to dividend seekersTrend Reversal & Safe Investment Capital Preservation Plans - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Verastem Inc. R (2VSA.DU) stock price, news, quote and history - Yahoo Finance UK

Dec 05, 2025
pulisher
Dec 04, 2025

Insider Sell: Dan Paterson Sells 6,000 Shares of Verastem Inc (V - GuruFocus

Dec 04, 2025
pulisher
Dec 04, 2025

Verastem President and CEO Dan Paterson Sells 6,000 Shares - TradingView

Dec 04, 2025
pulisher
Dec 04, 2025

CEO Paterson Sells 6,000 ($60.6K) Of Verastem Inc [VSTM] - TradingView

Dec 04, 2025
pulisher
Dec 03, 2025

XTX Topco Ltd Purchases New Position in Verastem, Inc. $VSTM - MarketBeat

Dec 03, 2025
pulisher
Dec 02, 2025

Verastem (VSTM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

Verastem (NASDAQ:VSTM) CEO Sells $21,580.00 in Stock - MarketBeat

Dec 02, 2025
pulisher
Dec 01, 2025

VSTM SEC FilingsVerastem 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 01, 2025
pulisher
Dec 01, 2025

Verastem Inc (VSTM) President and CEO Dan Paterson Sells 6,000 S - GuruFocus

Dec 01, 2025
pulisher
Nov 27, 2025

Verastem, Inc. $VSTM Stock Holdings Increased by Jefferies Financial Group Inc. - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

Verastem (NASDAQ:VSTM) Director Sells $85,500.00 in Stock - MarketBeat

Nov 26, 2025
pulisher
Nov 26, 2025

Aug Selloffs: Is Verastem Inc. stock a defensive play in 20252025 Pullback Review & Entry and Exit Point Strategies - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 26, 2025

EBITDA per share of Verastem, Inc. – TRADEGATE:2VSA - TradingView

Nov 26, 2025
pulisher
Nov 26, 2025

Insider Selling: Verastem (NASDAQ:VSTM) Director Sells 6,250 Shares of Stock - MarketBeat

Nov 26, 2025
pulisher
Nov 25, 2025

Verastem Announces Positive Data From Cancer Trial Conducted By Partner: Retail Turns Bullish - MSN

Nov 25, 2025
pulisher
Nov 25, 2025

Verastem Executives Engage in Stock Transactions - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

Dir Bunn Sells 6,250 ($62.5K) Of Verastem Inc [VSTM] - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

[Form 4] Verastem, Inc. Insider Trading Activity - Stock Titan

Nov 25, 2025
pulisher
Nov 25, 2025

CEO Paterson Sells 6,000 ($60K) Of Verastem Inc [VSTM] - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

Deep Track Capital, LP Acquires Significant Stake in Verastem Inc - GuruFocus

Nov 25, 2025
pulisher
Nov 25, 2025

Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference - MarketScreener

Nov 25, 2025
pulisher
Nov 25, 2025

United StatesMintz Advises On Verastem Oncology’s $103 Million Public Offering - Mondaq

Nov 25, 2025
pulisher
Nov 23, 2025

Understanding Momentum Shifts in (VSTM) - news.stocktradersdaily.com

Nov 23, 2025
pulisher
Nov 21, 2025

Dir Kauffman Files To Sell 8,550 Of Verastem Inc [VSTM] - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

Is Verastem Inc. (2VSA) stock considered safe havenIPO Watch & Accurate Entry and Exit Point Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How interest rate cuts could boost Verastem Inc. stock2025 Trade Ideas & Stock Portfolio Risk Management - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Verastem (NASDAQ:VSTM) Lowered to Hold Rating by Zacks Research - MarketBeat

Nov 21, 2025
pulisher
Nov 20, 2025

Balyasny Asset Management L.P. Increases Stake in Verastem Inc. - GuruFocus

Nov 20, 2025
pulisher
Nov 20, 2025

Verastem Oncology Prices $90 Million Public Offering - Global Legal Chronicle

Nov 20, 2025
pulisher
Nov 20, 2025

Verastem Inc. (VSTM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 20, 2025
pulisher
Nov 20, 2025

Is it too late to sell Verastem Inc.2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will Verastem Inc. stock deliver better than expected guidanceJuly 2025 Final Week & Accurate Buy Signal Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Institutional scanner results for Verastem Inc.July 2025 Market Mood & Real-Time Chart Pattern Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Verastem Inc. stock cheap at current valuationPortfolio Return Summary & Daily Entry Point Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Verastem Inc. stock supported by strong cash flowsTrade Risk Summary & Low Drawdown Trading Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Verastem Inc. stock remain a Wall Street favorite2025 Bull vs Bear & Stock Portfolio Risk Control - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Verastem Inc. (2VSA) stock undervalued after correction2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Verastem Inc. stock daily chart insightsPortfolio Performance Report & Accurate Buy Signal Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How supply chain issues affect Verastem Inc. stockWeekly Risk Summary & High Accuracy Buy Signal Tips - newser.com

Nov 19, 2025

Finanzdaten der Verastem Inc-Aktie (VSTM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.22
price down icon 1.12%
$95.83
price down icon 0.92%
$31.20
price down icon 2.35%
$96.74
price down icon 0.54%
biotechnology ONC
$322.77
price down icon 1.12%
$194.15
price down icon 1.32%
Kapitalisierung:     |  Volumen (24h):